Wall Street Has a Positive Outlook on MetLife, Inc. (MET)

Published on November 27, 2025 at 5:52 am by Talha Qureshi in News

MetLife, Inc. (NYSE:MET) is one of the Best Very Cheap Stocks to Invest In. Wall Street has a positive outlook on MetLife, Inc. (NYSE:MET) despite mixed results for fiscal Q3 2025. On November 11, Ryan Krueger from KBW lowered the price target on the stock from $92 to $90 and maintained a Buy rating. Earlier on November 7, Elyse Greenspan from Wells Fargo had also reiterated a Buy rating on the stock, but lowered the price target from $96 to $92.

The positive outlook follows the company’s fiscal Q3 2025 results, announced on November 5. The revenue decreased by 5.85% year-over-year to $17.36 billion, and fell short of the expectations by $789.2 million. On the bright side, the EPS of $2.37 topped estimates by $0.05.

Management attributed revenue loss to a large net investment loss of $325 million and a net derivative loss of $929 million. Despite this loss, the company was still able to increase its adjusted earnings per share by 21%, driven by strong variable investment income, broad-based volume growth, and diligent expense management.

MetLife, Inc. (NYSE:MET) is a global financial services company that provides insurance, annuities, employee benefits, and asset management services to individual and institutional customers.

Disclosure: None. This article is originally published at Insider Monkey.